129 related articles for article (PubMed ID: 15132705)
1. Poly(amidoamine) salt form: effect on pH-dependent membrane activity and polymer conformation in solution.
Wan KW; Malgesini B; Verpilio I; Ferruti P; Griffiths PC; Paul A; Hann AC; Duncan R
Biomacromolecules; 2004; 5(3):1102-9. PubMed ID: 15132705
[TBL] [Abstract][Full Text] [Related]
2. Poly(amidoamine)s as potential endosomolytic polymers: evaluation in vitro and body distribution in normal and tumour-bearing animals.
Richardson S; Ferruti P; Duncan R
J Drug Target; 1999; 6(6):391-404. PubMed ID: 10937285
[TBL] [Abstract][Full Text] [Related]
3. Understanding the mechanism of action of poly(amidoamine)s as endosomolytic polymers: correlation of physicochemical and biological properties.
Griffiths PC; Paul A; Khayat Z; Wan KW; King SM; Grillo I; Schweins R; Ferruti P; Franchini J; Duncan R
Biomacromolecules; 2004; 5(4):1422-7. PubMed ID: 15244460
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and endosomolytic properties of poly(amidoamine) block copolymers.
Lavignac N; Lazenby M; Foka P; Malgesini B; Verpilio I; Ferruti P; Duncan R
Macromol Biosci; 2004 Oct; 4(10):922-9. PubMed ID: 15495179
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and preliminary evaluation of poly(amidoamine)-melittin conjugates as endosomolytic polymers and/or potential anticancer therapeutics.
Lavignac N; Lazenby M; Franchini J; Ferruti P; Duncan R
Int J Pharm; 2005 Aug; 300(1-2):102-12. PubMed ID: 16009513
[TBL] [Abstract][Full Text] [Related]
6. Characterising the size and shape of polyamidoamines in solution as a function of pH using neutron scattering and pulsed-gradient spin-echo NMR.
Khayat Z; Griffiths PC; Grillo I; Heenan RK; King SM; Duncan R
Int J Pharm; 2006 Jul; 317(2):175-86. PubMed ID: 16621363
[TBL] [Abstract][Full Text] [Related]
7. Intracellular fate of bioresponsive poly(amidoamine)s in vitro and in vivo.
Richardson SC; Pattrick NG; Lavignac N; Ferruti P; Duncan R
J Control Release; 2010 Feb; 142(1):78-88. PubMed ID: 19822175
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cell membrane disruption by pH-responsive pseudo-peptides through grafting with hydrophilic side chains.
Chen R; Yue Z; Eccleston ME; Williams S; Slater NK
J Control Release; 2005 Nov; 108(1):63-72. PubMed ID: 16139914
[TBL] [Abstract][Full Text] [Related]
9. Tailor-made poly(amidoamine)s for controlled complexation and condensation of DNA.
Hartmann L; Häfele S; Peschka-Süss R; Antonietti M; Börner HG
Chemistry; 2008; 14(7):2025-33. PubMed ID: 18260067
[TBL] [Abstract][Full Text] [Related]
10. Poly(amidoamine)s as potential nonviral vectors: ability to form interpolyelectrolyte complexes and to mediate transfection in vitro.
Richardson SC; Pattrick NG; Man YK; Ferruti P; Duncan R
Biomacromolecules; 2001; 2(3):1023-8. PubMed ID: 11710005
[TBL] [Abstract][Full Text] [Related]
11. Novel bioreducible poly(amido amine)s for highly efficient gene delivery.
Lin C; Zhong Z; Lok MC; Jiang X; Hennink WE; Feijen J; Engbersen JF
Bioconjug Chem; 2007; 18(1):138-45. PubMed ID: 17226966
[TBL] [Abstract][Full Text] [Related]
12. Aqueous solution behaviour and membrane disruptive activity of pH-responsive PEGylated pseudo-peptides and their intracellular distribution.
Chen R; Yue Z; Eccleston ME; Slater NK
Biomaterials; 2008 Nov; 29(32):4333-40. PubMed ID: 18708250
[TBL] [Abstract][Full Text] [Related]
13. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
14. Poly(amidoamine)-mediated intracytoplasmic delivery of ricin A-chain and gelonin.
Pattrick NG; Richardson SC; Casolaro M; Ferruti P; Duncan R
J Control Release; 2001 Dec; 77(3):225-32. PubMed ID: 11733090
[TBL] [Abstract][Full Text] [Related]
15. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
[TBL] [Abstract][Full Text] [Related]
16. Novel poly(amido amine)s with bioreducible disulfide linkages in their diamino-units: structure effects and in vitro gene transfer properties.
Piest M; Lin C; Mateos-Timoneda MA; Lok MC; Hennink WE; Feijen J; Engbersen JF
J Control Release; 2008 Aug; 130(1):38-45. PubMed ID: 18585814
[TBL] [Abstract][Full Text] [Related]
17. Poly(amidoamine) conjugates with disulfide-linked cholesterol pendants self-assembling into redox-sensitive nanoparticles.
Ranucci E; Suardi MA; Annunziata R; Ferruti P; Chiellini F; Bartoli C
Biomacromolecules; 2008 Oct; 9(10):2693-704. PubMed ID: 18781798
[TBL] [Abstract][Full Text] [Related]
18. Poly(L-lysine) as a model drug macromolecule with which to investigate secondary structure and microporous membrane transport, part 2: diffusion studies.
Chittchang M; Salamat-Miller N; Alur HH; Vander Velde DG; Mitra AK; Johnston TP
J Pharm Pharmacol; 2002 Nov; 54(11):1497-505. PubMed ID: 12495552
[TBL] [Abstract][Full Text] [Related]
19. Bioresponsive poly(amidoamine)s designed for intracellular protein delivery.
Coué G; Freese C; Unger RE; Kirkpatrick CJ; Engbersen JF
Acta Biomater; 2013 Apr; 9(4):6062-74. PubMed ID: 23237985
[TBL] [Abstract][Full Text] [Related]
20. Functionalized linear poly(amidoamine)s are efficient vectors for intracellular protein delivery.
Coué G; Engbersen JF
J Control Release; 2011 May; 152(1):90-8. PubMed ID: 21277918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
